The EBRD announced on 12 January 2012 plans to acquire 15 per cent of pharmaceuticals distributor Katren for an estimated USD 38-60 million. The proceeds from the investment will be used to develop the distributor’s warehousing capacity and also to fund potential future acquisitions both in Russia and other CIS countries.
Katren is the third largest pharmaceuticals distributor in Russia. The Russian market accounted for 86 percent of Katren’s consolidated revenues in 2012.
As the EBRD notes in its press release on the deal, the bank has also acquired equity interests in Petrovax and the Healthy People pharmacy chain in Russia.